NCT02257424 · Interventional trial
Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
Overall registry status Completed
Phase 1 · Phase 2
Conditions Advanced BRAF Mutant Melanoma
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory